Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED
on 24 Aug 2021
Last Applicant/ Owned by
6 rue Alain Bombard
Saint Herblain
FR
F-44800
Serial Number
79156199 filed on 16th Jul 2014
Registration Number
4774813 registered on 21st Jul 2015
Correspondent Address
Christina M. Licursi
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
V VALNEVA
Scientific research services for medical purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research services for medical purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous systems, cardiovascular diseases, neurodegenerative and chronic diseases; scientific and industrial research, in particular in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, gene study, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing and evaluations of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; research and development of new products for human and veterinary use; scientific research, namely, preparation of scientific experts opinion reports in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific expert opinions reports
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical products for human and veterinary use for the treatment of auto immune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and pharmaceutical preparations for medical and veterinary use; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and pharmaceutical products, namely, preparation of encapsulated cells which release antibodies for medical and veterinary use; diagnostic products, namely, diagnostic preparations for use in human, veterinary medicine and pharmaceutical use; cell, microorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibiotics, vaccines, viruses, viral vectors, nucleic acids, proteins, recombinant proteins, peptides, peptide antigens, blood serum, antibodies and fragments thereof, and cells for medical, pharmaceutical and veterinary use; viral substances, immunological substances, bacterial substances, enzyme substances used for human and veterinary medicine; diagnostic kits consisting primarily of antibodies and fragments thereof for use in disease testing; diagnostic kits primarily of antibodies and antibody fragments for use in disease testing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical products, namely, fungicides, herbicides, insecticides and parasiticides for use in industry, science as well as in agriculture; molecules from bio technologies, namely, proteins in raw material for scientific and medical research; cells for scientific, laboratory or medical research; cell lines for scientific and medical research; nucleic acids for laboratory use; proteins for industrial use; recombinant proteins for industrial use; biomedical compounds, namely, peptides substrates; peptide antigens used in analyzing and detecting certain toxins for research, clinical, medical laboratory use; Biochemical preparations derived from blood serum for use in scientific and medical research; Bio chemicals, namely, antibodies and fragments thereof for in vitro scientific or research use, Chemicals for use in biotechnological product development; cultures of microorganisms other than for medical and veterinary use; viruses, cells, biological, bacteriological or viral preparations, other than for nucleic acids for scientific, laboratory, or medical research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79156199
Mark Type
No Service Mark
Attorney Docket Number
No I04222000400
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.13.14 -
Three or more quadrilaterals
26.13.16 -
Quadrilaterals touching or intersecting
26.13.21 -
Quadrilaterals that are completely or partially shaded
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Jul 2024 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| 07th Jun 2024 | INTERNATIONAL REGISTRATION RENEWED |
| 15th Oct 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 24th Aug 2021 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| 24th Aug 2021 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| 24th Aug 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 13th Apr 2021 | TEAS SECTION 71 & 15 RECEIVED |
| 21st Jul 2020 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 26th Sep 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
| 13th Dec 2018 | CHANGE OF NAME/ADDRESS REC'D FROM IB |